Product
Supplier
Encyclopedia
Inquiry
Home > News > Policy & Regulation
ECHEMI chemical news

Policy & Regulation

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

2024-01-11

The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.

AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?

AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?

2024-01-10

On January 9, pharmaceutical giant GlaxoSmithKline (GSK) announced its acquisition agreement with AiolosBio, a move aimed at strengthening its portfolio in the respiratory and inflammation drug market.

Can Lecanemab Revolutionize Alzheimer's Disease Treatment?

Can Lecanemab Revolutionize Alzheimer's Disease Treatment?

2024-01-10

Alzheimer's disease (AD) poses a significant challenge worldwide, affecting millions of individuals and their families. However, a breakthrough may be on the horizon with the recent approval of Lecanemab-irmb, a novel drug developed by Eisai

Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications

Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications

2024-01-10

According to a new federally-funded study by the National Institutes of Health, the drugs semaglutide, commonly used to treat diabetes and obesity, have been found to reduce the risk of suicide ideation in patients compared to other medications used for t

Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?

Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?

2024-01-08

In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted Florida permission to directly import prescription drugs from Canada.

Is FDA Doing Enough to Ensure the Safety of Food Additives?

Is FDA Doing Enough to Ensure the Safety of Food Additives?

2024-01-08

In a closely-watched development, California legislators recently passed a bill that could ban the sale of certain food additives in the state.

Announcement: ECHEMI Data Upgrade Notice

Announcement: ECHEMI Data Upgrade Notice

2024-01-04

The ECHEMI data server will be upgraded. After the upgrade, the stability and data timeliness in 2024 can be significantly improved.

Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?

Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?

2024-01-04

The US Food and Drug Administration (FDA) is closely examining reports of potential side effects associated with certain medications like Ozempic, Mounjaro, and Wegovy.

Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach

Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach

2024-01-03

Meditox, a Korean botulinum toxin (BTX) manufacturer, said it has established a U.S. subsidiary, Luvantas, to enter the global market with its non-animal-derived liquid BTX preparation MT10109L.

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals

2023-12-28

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals.

Avoiding Misdiagnosis: The FDA's Warning on False Positive Results in Genital Herpes Testing
What Changes Does the Latest MFDS Announcement Bring to South Korea's Functional Food Regulations?

What Changes Does the Latest MFDS Announcement Bring to South Korea's Functional Food Regulations?

2023-12-27

The South Korean Ministry of Food and Drug Safety (MFDS) has recently issued Notice No. 2023-91, introducing amendments to certain provisions of the "Health Functional Food Code."

Can New Entrants Succeed in the Competitive GLP-1 Drug Market?

Can New Entrants Succeed in the Competitive GLP-1 Drug Market?

2023-12-27

The expanding potential of GLP-1 drugs has attracted significant attention from pharmaceutical companies worldwide. Analysts predict that annual sales of GLP-1-related drugs could exceed $100 billion by 2030, creating a highly lucrative market.

Is Switzerland Strengthening Food Safety Regulations with Revised Processing Food Regulations?

Is Switzerland Strengthening Food Safety Regulations with Revised Processing Food Regulations?

2023-12-26

The question arises: Is Switzerland strengthening food safety regulations with the revised processing food regulations? The revised regulations indeed demonstrate Switzerland's commitment to enhancing food safety measures.

New EPA Regulation Sets Temporary Maximum Residue Limits for Kasugamycin in Selected Products

New EPA Regulation Sets Temporary Maximum Residue Limits for Kasugamycin in Selected Products

2023-12-20

The United States Environmental Protection Agency (EPA) recently issued Regulation No. 2023-27654 on December 18, 2023.

 The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes

The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes

2023-12-18

The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes

China's Active Pharmaceutical Ingredients Industry Analysis - Driving China's Pharmaceutical Industry: Unveiling the Power of National Policies

China's Active Pharmaceutical Ingredients Industry Analysis - Driving China's Pharmaceutical Industry: Unveiling the Power of National Policies

2023-12-15

China's pharmaceutical industry is experiencing a transformative period driven by strategic national policies aimed at fostering high-quality development, enhancing production standards, and promoting environmental sustainability.

Setbacks in Cell Therapy: FDA Halts Clinical Trials of Three Biotech's Products

Setbacks in Cell Therapy: FDA Halts Clinical Trials of Three Biotech's Products

2023-12-15

Biotech company SciGene Pharmaceuticals, specializing in cell therapy, revealed that it had received a notice from the U.S. Food and Drug Administration (FDA) on the previous day, ordering the temporary halt of clinical trials for its products CT053, CT04

Sirona Biochem Corp to Trademark Anti-aging Molecule as GlycoProteMim

Sirona Biochem Corp to Trademark Anti-aging Molecule as GlycoProteMim

2023-12-13

Sirona Biochem has begun the trademarking process through it’s subsidiary, TFChem and is engaging industry experts to plan for commercializing GlycoProteMim.

Crystal India acquips Syngenta's herbicide Gramoxone(Paraquat)trademark for use in its market

Crystal India acquips Syngenta's herbicide Gramoxone(Paraquat)trademark for use in its market

2023-12-12

Crystal India recently announced the acquisition of the herbicide Gramoxone (active ingredient: Paraquat) trademark from Syngenta for use in the Indian market.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.